Fludara and Peripheral swelling - a phase IV clinical study of FDA data

Summary:

Peripheral swelling is reported as a side effect among people who take Fludara (fludarabine phosphate), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Cyclophosphamide, and have Chronic lymphocytic leukaemia.

The phase IV clinical study analyzes which people have Peripheral swelling when taking Fludara. It is created by eHealthMe based on reports of 46,669 people who have side effects when taking Fludara from the FDA, and is updated regularly.

What is Fludara?

Fludara has active ingredients of fludarabine phosphate. eHealthMe is studying from 46,686 Fludara users. Check the latest studies of Fludara.

What is Peripheral swelling?

Peripheral swelling is found to be associated with 2,180 drugs and 1,741 conditions by eHealthMe. Check the latest studies of Peripheral swelling.

On Jul, 19, 2026

46,669 people reported to have side effects when taking Fludara.
Among them, 45 people (0.1%) have Peripheral swelling.

Could Fludara cause Peripheral swelling?

Among these 45 people:

How long have people been on Fludara when they have Peripheral swelling? *

What is the gender of people who have Peripheral swelling when taking Fludara? *

female: 39.47 %
male: 60.53 %

What is the age of people who have Peripheral swelling when taking Fludara? *

What are other drugs people take besides Fludara? *

What are other side effects people have besides Peripheral swelling? *

Weakness: 10 people, 22.22%
Cytokine Release Syndrome (immediate complication occurring with the use of anti-t cell antibody infusions): 10 people, 22.22%
Skin Mass: 9 people, 20.00%
Fever: 9 people, 20.00%
Skin Exfoliation (removal of the oldest dead skin cells): 9 people, 20.00%
White Blood Cell Count Decreased: 8 people, 17.78%
Granuloma Skin (a small area of inflammation on skin due to tissue injury): 8 people, 17.78%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 8 people, 17.78%
Thrombocytopenia (decrease of platelets in blood): 8 people, 17.78%
Nausea And Vomiting: 7 people, 15.56%

What are the existing conditions these people have? *

Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 13 people, 28.89%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 7 people, 15.56%
Bone Marrow Conditioning Regimen: 6 people, 13.33%
Burkitt Lymphoma (cancer of the lymphatic system): 5 people, 11.11%
B-Cell Small Lymphocytic Lymphoma (blood cancer affecting b cells): 5 people, 11.11%
Nausea (feeling of having an urge to vomit): 4 people, 8.89%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 4 people, 8.89%
Itching: 3 people, 6.67%
Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 3 people, 6.67%
Flatulence (flatus expelled through the anus): 3 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Fludara and have Peripheral swelling?

- Check whether Peripheral swelling is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Fludara:

Fludara (46,686 reports)

Browse all side effects of Fludara:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Peripheral swelling:

Peripheral swelling (2,180 drugs)

Browse all the conditions that are associated with Peripheral swelling:

Peripheral swelling (1,741 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on fludarabine phosphate (the active ingredients of Fludara) and Fludara (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.